173 filings
Page 5 of 9
8-K
zqpnyjfgjf0 uj
19 Aug 20
Timber Pharmaceuticals Announces Appointment of Dr. David Cohen and Dr. Lubor Gaal to Board of Directors
4:27pm
8-K
tun0jtlt2ds58bdakdff
18 Aug 20
Timber Pharmaceuticals Provides Business Update and Announces Second Quarter 2020 Financial Results
4:54pm
8-K/A
kzmrigewud aetl8
2 Jul 20
Changes in Registrant's Certifying Accountant
5:15pm
8-K
i2g czmmq7f7
3 Jun 20
Entry into a Material Definitive Agreement
4:06pm
8-K
z3ilkt 9c1anci
22 May 20
Timber Pharmaceuticals Announces Merger Closing
5:16pm
8-K
rbqj5xi u3
15 May 20
BioPharmX Announces 1-for-12 Reverse Stock Split
4:30pm
8-K
ftcdygpdt4c3fp7y
13 May 20
BioPharmX Corporation Announces Approval of Merger by Stockholders at Special Meeting
4:33pm
8-K
y9m1xavvp8 4r
11 May 20
Other Events
4:08pm
8-K
ea5ohydq86l
27 Apr 20
BioPharmX Corporation Announces that its Special Stockholders’ Meeting
4:12pm
8-K
4ex4rdpk
6 Apr 20
Timber Pharmaceuticals Announces Award of Second Tranche of FDA Orphan Products Clinical Trials Grant
4:54pm
8-K
5y9dbwm5pgdinhpn
30 Mar 20
BioPharmX Receives Notice of Delisting from NYSE American But Stock will Remain Trading
4:03pm
8-K
sn45i61g tmn1gqu
18 Feb 20
Entry into a Material Definitive Agreement
4:04pm
8-K
4uwemisyr7qkkpoi
3 Feb 20
Departure of Directors or Certain Officers
9:00am
8-K
p7r7cqu0kcdf96d w1i3
29 Jan 20
BioPharmX and Timber Pharmaceuticals Announce Entry into Merger Agreement
4:33pm
8-K
krr2zn2aq7ofgv1w
10 Dec 19
BioPharmX Reports Fiscal Third Quarter 2020 Financial Results and Provides Corporate Update
4:06pm
8-K
ze6o96lz 4tp57q8a25
20 Sep 19
BioPharmX Receives Notice of Compliance Deadline Extension from NYSE American
4:08pm
8-K
iagmwzc1
9 Sep 19
BioPharmX Reports Fiscal Second Quarter 2020 Financial Results and Provides Corporate Update
8:16am
8-K
ico29
17 Jul 19
BioPharmX Announces Steven M. Bosacki Joins the Company as Chief Operating Officer
4:12pm
8-K
xdug0zvfonr
11 Jul 19
Submission of Matters to a Vote of Security Holders
4:25pm
8-K
a1g1acnq 9zol
25 Jun 19
BioPharmX Announces Positive Topline Results from Phase 2b Trial of BPX-04 for Papulopustular Rosacea
8:00am